- Fixing the Implementation Gap: Best Practices for Validating a Test Method to Inform Regulatory Decision-Making
-
Hemisfair Ballroom C3‚ Convention Center
Chair: Alison Harrill, Corteva Agriscience
Co-Chair: Helena Hogberg, NIH/ORIVA
Primary Endorser: Regulatory and Safety Evaluation Specialty Section
Endorser(s): In Vitro and Alternative Methods Specialty Section
Endorser(s): Women in Toxicology Special Interest GroupAs the field of toxicology increasingly shifts toward adoption of test method refinements and alternative testing strategies, the demand for robust, reliable data to inform regulatory decision making has never been greater. Test methods - including new approach methods (NAMs) – that are utilized in support of health assessment of chemicals must be reproducible, biologically and/or mechanistically relevant, and fit-for-purpose. However, the principles and best practices critical for rigorous test method validation are often underappreciated, underfunded, and often learned only from direct, practical experience with validation programs. Consequently, many promising methodologies struggle to bridge the gap between early-stage development and regulatory acceptance. To address this challenge, several method validation frameworks have been recently developed to help guide assay developers and regulatory bodies on approaches to test method validation. This session will highlight these frameworks, including guidance on U.S. interagency practices and international harmonization via the OECD’s update and modernization of its guidance document on the validation and international acceptance of new or updated test methods for hazard assessment. The first talk will discuss new and emerging validation frameworks, highlighting the importance of readiness criteria and decision gating to ensure methods are truly prepared for formal evaluation before significant resources are invested. The next two talks will examine detailed case studies in test method development and validation, demonstrating where framework concepts are applied in interlaboratory reproducibility studies. These case studies will provide practical perspectives from both a regulatory agency and the regulated industry. Ultimately, attendees will leave with actionable insights on how to navigate the complex method validation landscape, ensuring that there is sufficient scientific support to have confidence in using data derived from innovative test methods in regulatory contexts, where the bar is necessarily high. Such insights will include the importance of technical characterization and assessing readiness of a test method to enter time- and resource-intensive between-lab transferability studies, with practical examples provided. A panel discussion to follow will focus on the role of professional method validation organizations and how partnering with experienced program managers can help inform the technical readiness, reproducibility, and fitness-for-purpose to ease regulatory uptake.
Session and Activity Type
Enter Note
Go to previous page in this tab
Event
